PROK
PROK
NASDAQ · Biotechnology

Prokidney Corp

$1.79
-0.04 (-2.19%)
As of Sep 23, 2:30 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 10 67%
Hold 4 27%
Sell 1 7%
Price Target
Analyst Price Target +1,007.3% upside
Low Target $13.43
Average Target $19.82
High Target $25.07
Current Price $1.79
Current
$1.79
Target
$19.82
$13.43 $19.82 avg $25.07
Scenario Analysis
Bear Case
$13.43
650.3%
Low target
Base Case
$19.82
+1,007.3%
Avg target
Bull Case
$25.07
+1,300.6%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.48
-48.6% from high
52-Week Low
$1.30
+37.7% from low
Target vs 52W High
$19.82
+469.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.8%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -15.1%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -17.9%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.2%